Back
Hepion Pharmaceuticals 10K Form
Sell
23
HEPA
Hepion Pharmaceuticals
Last Price:
0.63
Seasonality Move:
10.8%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HEPA News And Ratings
See the #1 stock for the next 7 days that we like better than HEPA
HEPA Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-10.93M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.32 |
| Price / Book: | 1.99 |
Profitability
| EPS (TTM): | -6.40000 |
|---|---|
| Net Income (TTM): | $-28.37M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Hepion Pharmaceuticals Earnings Forecast
Key Hepion Pharmaceuticals Financial Ratios
- The Interest Expense is -0.02% of Operating Income.
- Per Share Earnings over the last 10 years have been positive in 5 years.
Hepion Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | HEPA |
| CUSIP: | 426897 |
| Website: | hepionpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
HEPA Technical Analysis vs Fundamental Analysis
Sell
23
Hepion Pharmaceuticals (HEPA)
is a Sell
Is Hepion Pharmaceuticals a Buy or a Sell?
-
Hepion Pharmaceuticals stock is rated a Sell
The current Hepion Pharmaceuticals [HEPA] share price is $0.64. The Score for HEPA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.